Patent US4857511A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4857511A Expired / Lapsed US ⏱️ 0.0 years remaining

Treatment of human viral infections

Assignee: SmithKline Beecham Corp
•
Filing: 1988-02-08
•
Granted: 1989-08-15
•
Expires: 2008-02-08
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Treatment of AIDS or humans carrying or infected with the AIDS virus or having antibodies to the AIDS virus is disclosed using the compound 3'-azido-3'-deoxythymidine or a pharmaceutically acceptable basic salt thereof. Also disclosed is the use of the 5'-mono-, di- and triphosphate of 3'-azido-3'-deoxythymidine or a pharmaceutically acceptable basic salt thereof for the same purpose.

Inventors

  • 👤 Janet L. Rideout
  • 👤 David W. Barry
  • 👤 Sandra N. Lehrman
  • 👤 Martha H. St. Clair
  • 👤 Phillip A. Furman

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-09 16:52
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/70; C; C07; C07H; C07H19/00; C07H19/02; C07H19/04; C07H19/06; C07H19/10; C07H19/16

Claims Analysis

Total Claims: 4
Claim 1
Independent Claim 36 words
A method of treating a human having AIDS and who is also being administered acyclovir, which comprises administering to said human an effective AIDS treatment amount of the compound 3'-azido-3'-deoxythymidine or a pharmaceutically acceptable salt thereof.
Claim 2
Independent Claim 36 words
A method of treating a human having AIDS and who is also being administered acyclovir, which comprises administering to said human an effective AIDS treatment amount of the compound 3'-azido-3'-deoxythymidine or a pharmaceutically acceptable salt thereof.
Claim 3
Dependent Claim 16 words
A method of claim 1, in which the compound 3'-azido-3'-deoxythymidine is administered orally or by injection.
Claim 4
Dependent Claim 18 words
A method of claim 1, in which the compound or salt thereof is administered orally or by injection.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1992-08-14 1993-02-13 1993-08-15 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1996-08-14 1997-02-13 1997-08-15 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2000-08-14 2001-02-13 2001-08-15 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag